PetLife Pharmaceuticals Seeks Financing for FDA Application

PetLife Pharmaceuticals (OTCQB:PTLF) is pursuing investment, asset, and banking service firm Carter, Terry & Company for $4 million which would fund the company’s FDA application of cancer treatments in pets.

As quoted in the press release:

“The funds raised will significantly progress the Company toward bringing VitalZul™ to our customers, the families of pets with cancer,” said Dr. Ralph Salvagno, CEO of PetLife Pharmaceuticals. “Our Company is at the forefront of the fight against cancer in pets, and this round of fundraising is a vote of confidence in our product and company vision.”

Click here to read the full press release.

Get the Latest Pharmaceutical Investing Stock Information

Get the latest information about companies associated with Pharmaceutical Investing delivered directly to your inbox.


By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time.


Leave a Reply